P2X7 receptor activation contributes to an initial upstream mechanism of lipopolysaccharideinduced vascular dysfunction

Clinical Science

Volumn 125, Issue 3, 2013, Pages 131-141

  Chiao, Chin Wei ^a,b   da Silva santos, J Eduardo ^a,c   Giachini, Fernanda R ^a   Tostes, Rita C ^a,d   Su, Ming Jai ^b   Webb, R Clinton ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

^d UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Cyclo oxygenase; Interleukin 1 ; lipopolysaccharide; Nitric oxide synthase; P2X7 receptor; Sepsis; Tumour necrosis factor

Indexed keywords

CYCLOOXYGENASE 2; ENDOTHELIAL NITRIC OXIDE SYNTHASE; INDOMETACIN; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 1 RECEPTOR ACCESSORY PROTEIN; INTERLEUKIN 10; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; NORADRENALIN; PHENYLEPHRINE; PURINERGIC P2X7 RECEPTOR; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA; CYTOKINE; IL1RN PROTEIN, HUMAN; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; NOS3 PROTEIN, MOUSE; PTGS2 PROTEIN, MOUSE; TLR4 PROTEIN, MOUSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL REACTIVITY; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; KNOCKOUT MOUSE; MEAN ARTERIAL PRESSURE; MESENTERIC ARTERY; MOLECULAR MECHANICS; MOUSE; NONHUMAN; PRESSOR RESPONSE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION; VASCULAR DISEASE; VASCULAR RING; WESTERN BLOTTING; WILD TYPE; ANIMAL; BLOOD PRESSURE; C57BL MOUSE; DRUG EFFECT; MALE; PHYSIOLOGY; SECRETION (PROCESS); VASOCONSTRICTION;

ANIMALS; BLOOD PRESSURE; CYCLOOXYGENASE 2; CYTOKINES; INDOMETHACIN; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; LIPOPOLYSACCHARIDES; MALE; MICE; MICE, INBRED C57BL; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE TYPE III; NOREPINEPHRINE; RECEPTORS, PURINERGIC P2X7; TOLL-LIKE RECEPTOR 4; VASOCONSTRICTION;

MLCS; MLOWN;

EID: 84878439301     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/CS20120479     Document Type: Article

References (39)

1. Riedemann, N. C., Guo, R. F. and Ward, P. A. (2003) Novel strategies for the treatment of sepsis. Nat. Med. 9, 517-524
2. Ralevic, V. and Burnstock, G. (1998) Receptors for purines and pyrimidines. Pharmacol. Rev. 50, 413-492
3. Burnstock, G. and Knight, G. E. (2004) Cellular distribution and functions of P2 receptor subtypes in different systems. Int. Rev. Cytol. 240, 31-304
4. Di Virgilio, F. (1995) The P2Z purinoceptor: an intriguing role in immunity, inflammation and cell death. Immunol. Today 16, 524-528
5. Falzoni, S., Munerati, M., Ferrari, D., Spisani, S., Moretti, S. and Di Virgilio, F. (1995) The purinergic P2Z receptor of human macrophage cells. Characterization and possible physiological role. J. Clin. Invest. 95, 1207-1216
6. Buell, G. N., Talabot, F., Gos, A., Lorenz, J., Lai, E., Morris, M. A. and Antonarakis, S. E. (1998) Gene structure and chromosomal localization of the human P2X7 receptor. Receptors Channels 5, 347-354
7. Ferrari, D., Pizzirani, C., Adinolfi, E., Lemoli, R. M., Curti, A., Idzko, M., Panther, E. and Di Virgilio, F. (2006) The P2X7 receptor: a key player in IL-1 processing and release. J. Immunol. 176, 3877-3883
8. Denlinger, L. C., Fisette, P. L., Sommer, J. A., Watters, J. J., Prabhu, U., Dubyak, G. R., Proctor, R. A. and Bertics, P. J. (2001) Cutting edge: the nucleotide receptor P2X7 contains multiple protein- and lipid-interaction motifs including a potential binding site for bacterial lipopolysaccharide. J. Immunol. 167, 1871-1876
9. Ferrari, D., Chiozzi, P., Falzoni, S., Dal Susino, M., Melchiorri, L., Baricordi, O. R. and Di Virgilio, F. (1997) Extracellular ATP triggers IL-1β release by activating the purinergic P2Z receptor of human macrophages. J. Immunol. 159, 1451-1458
10. Labasi, J. M., Petrushova, N., Donovan, C., McCurdy, S., Lira, P., Payette, M. M., Brissette, W., Wicks, J. R., Audoly, L. and Gabel, C. A. (2002) Absence of the P2X7 receptor alters leukocyte function and attenuates an inflammatory response. J. Immunol. 168, 6436-6445
11. Solle, M., Labasi, J., Perregaux, D. G., Stam, E., Petrushova, N., Koller, B. H., Griffiths, R. J. and Gabel, C. A. (2001) Altered cytokine production in mice lacking P2X7 receptors. J. Biol. Chem. 276, 125-132
12. Chiao, C. W., Tostes, R. C. and Webb, R. C. (2008) P2X7 receptor activation amplifies lipopolysaccharide-induced vascular hyporeactivity via interleukin-1β release. J. Pharmacol. Exp. Ther. 326, 864-870
13. Perregaux, D. and Gabel, C. A. (1994) Interleukin-1β maturation and release in response to ATP and nigericin. Evidence that potassium depletion mediated by these agents is a necessary and common feature of their activity. J. Biol. Chem. 269, 15195-15203
14. Sanz, J. M. and Di Virgilio, F. (2000) Kinetics and mechanism of ATP-dependent IL-1β release from microglial cells. J. Immunol. 164, 4893-4898
15. Beasley, D., Cohen, R. A. and Levinsky, N. G. (1989) Interleukin 1 inhibits contraction of vascular smooth muscle. J. Clin. Invest. 83, 331-335
16. Dinarello, C. A. and Wolff, S. M. (1993) The role of interleukin-1 in disease. N. Engl. J. Med. 328, 106-113
17. Takizawa, S., Ozaki, H. and Karaki, H. (1999) Possible involvement of K+ channel opening to the interleukin-1β-induced inhibition of vascular smooth muscle contraction. J. Vet. Med. Sci. 61, 357-360
18. Guerra, A. N., Fisette, P. L., Pfeiffer, Z. A., Quinchia-Rios, B. H., Prabhu, U., Aga, M., Denlinger, L. C., Guadarrama, A. G., Abozeid, S., Sommer, J. A. et al. (2003) Purinergic receptor regulation of LPS-induced signaling and pathophysiology. J. Endotoxin Res. 9, 256-263
19. Pernerstorfer, T., Hollenstein, U., Hansen, J., Knechtelsdorfer, M., Stohlawetz, P., Graninger, W., Eichler, H. G., Speiser, W. and Jilma, B. (1999) Heparin blunts endotoxin-induced coagulation activation. Circulation 100, 2485-2490
20. Oury, C., Toth-Zsamboki, E., Vermylen, J. and Hoylaerts, M. F. (2006) The platelet ATP and ADP receptors. Curr. Pharm. Des. 12, 859-875
21. Wylam, M. E., Metkus, A. P. and Umans, J. G. (2001) Nitric oxide dependent and independent effects of in vitro incubation or endotoxin on vascular reactivity in rat aorta. Life Sci. 69, 455-467
22. Zhang, G., Han, J., Welch, E. J., Ye, R. D., Voyno-Yasenetskaya, T. A., Malik, A. B., Du, X. and Li, Z. (2009) Lipopolysaccharide stimulates platelet secretion and potentiates platelet aggregation via TLR4/MyD88 and the cGMP-dependent protein kinase pathway. J. Immunol. 182, 7997-8004
23. Ward, J. R., West, P. W., Ariaans, M. P., Parker, L. C., Francis, S. E., Crossman, D. C., Sabroe, I. and Wilson, H. L. (2010) Temporal interleukin-1β secretion from primary human peripheral blood monocytes by P2X7-independent and P2X7-dependent mechanisms. J. Biol. Chem. 285, 23147-23158
24. Izeboud, C. A., Hoebe, K. H., Grootendorst, A. F., Nijmeijer, S. M., van Miert, A. S., Witkamp, R. R. and Rodenburg, R. J. (2004) Endotoxin-induced liver damage in rats is minimized by β2-adrenoceptor stimulation. Inflamm. Res. 53, 93-99
25. Dinarello, C. A. (2000) The role of the interleukin-1-receptor antagonist in blocking inflammation mediated by interleukin-1. N. Engl. J. Med. 343, 732-734
26. Kellogg, Jr., D. L., Zhao, J. L. and Wu, Y. (2009) Roles of nitric oxide synthase isoforms in cutaneous vasodilation induced by local warming of the skin and whole body heat stress in humans. J. Appl. Physiol. 107, 1438-1444
27. Seddon, M. D., Chowienczyk, P. J., Brett, S. E., Casadei, B. and Shah, A. M. (2008) Neuronal nitric oxide synthase regulates basal microvascular tone in humans in vivo. Circulation 117, 1991-1996
28. Vanhoutte, P. M. (1998) Vascular biology. Old-timer makes a comeback. Nature 396, 213-216
29. Tracey, K. J. and Cerami, A. (1993) Tumor necrosis factor, other cytokines and disease. Annu. Rev. Cell Biol. 9, 317-343
30. Beutler, B. and Cerami, A. (1989) The biology of cachectin/TNF - a primary mediator of the host response. Annu. Rev. Immunol. 7, 625-655
31. Thiemermann, C., Wu, C. C., Szabo, C., Perretti, M. and Vane, J. R. (1993) Role of tumour necrosis factor in the induction of nitric oxide synthase in a rat model of endotoxin shock. Br. J. Pharmacol. 110, 177-182
32. Gourine, A. V., Poputnikov, D. M., Zhernosek, N., Melenchuk, E. V., Gerstberger, R., Spyer, K. M. and Gourine, V. N. (2005) P2 receptor blockade attenuates fever and cytokine responses induced by lipopolysaccharide in rats. Br. J. Pharmacol. 146, 139-145
33. Johns, D. G. and Webb, R. C. (1998) TNFα-induced endothelium-independent vasodilation: a role for phospholipase A2-dependent ceramide signaling. Am. J. Physiol. 275, H1592-H1598
34. Zemse, S. M., Chiao, C. W., Hilgers, R. H. and Webb, R. C. (2010) Interleukin-10 inhibits the in vivo and in vitro adverse effects of TNFα on the endothelium of murine aorta. Am. J. Physiol. Heart Circ. Physiol. 299, H1160-H1167
35. Bethea, J. R., Gillespie, G. Y. and Benveniste, E. N. (1992) Interleukin-1β induction of TNFα gene expression: involvement of protein kinase C. J. Cell Physiol. 152, 264-273
36. Hung, A. C., Chu, Y. J., Lin, Y. H., Weng, J. Y., Chen, H. B., Au, Y. C. and Sun, S. H. (2005) Roles of protein kinase C in regulation of P2X7 receptor-mediated calcium signalling of cultured type-2 astrocyte cell line, RBA-2. Cell. Signalling 17, 1384-1396
37. de Waal, M. R., Abrams, J., Bennett, B., Figdor, C. G. and de Vries, J. E. (1991) Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J. Exp. Med. 174, 1209-1220
38. Oberholzer, A., Oberholzer, C. and Moldawer, L. L. (2002) Interleukin-10: a complex role in the pathogenesis of sepsis syndromes and its potential as an anti-inflammatory drug. Crit. Care Med. 30, S58-S63
39. Arulkumaran, N., Unwin, R. J. and Tam, F. W. (2011) A potential therapeutic role for P2X7 receptor (P2X7R) antagonists in the treatment of inflammatory diseases. Expert Opin. Investig. Drugs 20, 897-915